NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 30, 2025 $1.41 -1.60% $1.55 X 90.78% 0
Apr 29, 2025 $1.38 -2.48% $1.43 X 96.16% 0
Apr 29, 2025 $1.39 -1.55% $1.43 X 97.07% 0
Apr 28, 2025 $1.37 -2.49% $1.41 X 96.82% 0
Apr 28, 2025 $1.38 -1.56% $1.41 X 97.75% 0
Apr 25, 2025 $1.31 -2.50% $1.40 X 93.32% 0
Apr 25, 2025 $1.32 -1.56% $1.40 X 94.22% 0
Apr 23, 2025 $1.26 -2.66% $1.31 X 95.86% 0
Apr 23, 2025 $1.27 -1.66% $1.31 X 96.84% 0
Apr 22, 2025 $1.25 -2.73% $1.29 X 97.27% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE